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Abstract Inositol polyphosphates, in their water-soluble or lipid-bound forms,
represent a large and multifaceted family of signalling molecules. Some inositol
polyphosphates are well recognised as defining important signal transduction
pathways, as in the case of the calcium release factor Ins(1,4,5)P3, generated by
receptor activation-induced hydrolysis of the lipid PtdIns(4,5)P2 by phospholipase
C. The birth of inositol polyphosphate research would not have occurred without the
use of radioactive phosphate tracers that enabled the discovery of the ‘‘PI response’’.
Radioactive labels, mainly of phosphorus but also carbon and hydrogen (tritium),
have been instrumental in the development of this research field and the estab-
lishment of the inositol polyphosphates as one of the most important networks of
regulatory molecules present in eukaryotic cells. Advancements in microscopy and
mass spectrometry and the development of colorimetric assays have facilitated
inositol polyphosphate research, but have not eliminated the need for radioactive
experimental approaches. In fact, such experiments have become easier with the
cloning of the inositol polyphosphate kinases, enabling the systematic labelling of
specific positions of the inositol ring with radioactive phosphate. This approach has
been valuable for elucidating their metabolic pathways and identifying specific and
novel functions for inositol polyphosphates. For example, the synthesis of radio-
labelled inositol pyrophosphates has allowed the discovery of a new protein post-
translational modification. Therefore, radioactive tracers have played and will
continue to play an important role in dissecting the many complex aspects of
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inositol polyphosphate physiology. In this review we aim to highlight the historical
importance of radioactivity in inositol polyphosphate research, as well as its modern
usage.
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1 Introduction
Inositol polyphosphates comprise a vast and multifaceted family of cellular
metabolites. The size of the family is explained by the ability to combinatorially
substitute the six hydroxyls of the myo-inositol ring with phosphate moieties:
mathematically, 64 such combinations are possible [1]. This number is in fact an
underestimate, as diphosphate (or pyrophosphate) moieties also exist [2– 4]. Among
these myriad inositol polyphosphates, without doubt the most famous is the calcium
release factor Ins(1,4,5)P3, the prototypical second messenger. Hydrolysis of the
lipid bond of PtdIns(4,5)P2 by phospholipase C (PLC) following receptor activation
to release the water-soluble Ins(1,4,5)P3 and the lipid diacylglycerol (DAG) is a
textbook example of signal transduction (Fig. 1) [5, 6]. It results in Ins(1,4,5)P3
binding to the InsP3 receptor and the consequent release of calcium from
intracellular stores [7].
This PLC activity was indirectly assayed during the first discovery of receptor-
stimulated inositol polyphosphate metabolism. In the early 1950s, the Hokin
husband and wife team were studying RNA metabolism using radioactive
orthophosphate [32P] metabolic labelling, when they discovered an increase in
cellular incorporation of radioactivity when pancreatic slices were stimulated with
acetylcholine. Surprisingly, however, the large majority of radioactivity was not
incorporated into nucleic acids but into the inositol-containing lipids called
phosphoinositides (PI or PtdInsP, phosphatidylinositols); this acetylcholine-stimu-
lated [32P] incorporation was therefore termed the ‘‘PI response’’ [8, 9]. It was not
until three decades later that the PI response was determined to be part of PLC
activation [6, 10] (Fig. 1). The [32P] taken up is initially incorporated into ATP and
other nucleotides. Radioactive phosphorylation of DAG to phosphatidic acid (PA)
allows its reattachment to inositol, creating PtdIns that is further phosphorylated,
generating the radioactive PtdInsP/‘‘PI’’ that the Hokins observed, and completing
what is now known as the inositol cycle (Fig. 1).
This short historical background highlights the fundamental importance of
radioactive phosphate labelling in the birth of the phosphoinositide and inositol
polyphosphate signalling research fields. Equally, everyone is aware of the
historical—and indeed, current—importance of radioactive labelling in nucleic
acid research [11]. Without radioactivity-based methods, molecular biology would
not have emerged and we would not be in the post-genomic era of biomedical
research. It is not an overstatement to say that without radioactivity, the advances in
biomedical science and consequent improvements in human health of the past
century would not have been achieved. The ongoing importance of radioactive
labelling to inositol polyphosphate research should also not be underestimated.
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The general perception of ‘‘radioactivity’’ is one of fear, and understandably so,
considering famous disasters such as those at Chernobyl or Fukushima [12].
However, using very low trace levels of radioactivity in a highly controlled research
environment is safe: many protection and monitoring measures are available
[13, 14]. Young researchers should therefore embrace radioactivity-based tech-
niques, as they offer unique research opportunities, even in this twenty-first century,
and especially in the inositol polyphosphate research field. Inositol polyphosphates,
being unable to absorb UV/visible wavelength light, cannot be detected by
absorbance or fluorescence methods. Thus the study of their metabolism and
physiological functions has only been possible through radioactivity experiments.
The current essay will focus primarily on the importance of radioactive phosphate
labelling ([32P] and [33P]) in inositol polyphosphate biology. We will discuss the use
of radioactive orthophosphate tracers to study the cellular metabolism of inositol
Fig. 1 Schematic representation of the inositol cycle. Inositol acquired from the extracellular space is
incorporated into lipids by the action of the phosphatidylinositol synthase (PI-synthase). The conversion
of PtdIns (PI), first to PtdIns(4)P (PIP) and then to PtdIns(4,5)P2 (PIP2), generates the substrate for
phospholipase C (PLC, boxed in red). Once receptor activation occurs, PLC generates two second
messengers: the (plasma) membrane-resident diacylglycerol (DAG) and the calcium (Ca2?) release factor
Ins(1,4,5)P3 (IP3). The latter is converted back to inositol via two dephosphorisation steps, closing the
cycle. The inositol cycle is particularly active in stimulated mammalian cells. The Hokin ‘‘PI response’’
[8, 9] measures the [32P] taken up by the cell and its conversion to [32P] cATP, with the subsequent
radioactive phosphorylation of DAG to phosphatidic acid (PA). PA is then reattached to inositol, creating
radioactive PI. For graphical reasons, inositol is abbreviated here as ‘‘I’’ instead of ‘‘Ins’’, and
phosphatidylinositol as ‘‘PI’’ instead of ‘‘PtdIns’’
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polyphosphates, as well as the biochemical synthesis and purification of inositol
polyphosphates radiolabelled at specific positions on the inositol ring. To provide a
complete view of relevant radioactive methods, we will also concisely describe the
use of radioactive hydrogen (tritium [3H]) and carbon (carbon-14 or [14C]) labelling
techniques.
2 Phosphoinositides and Inositol Phosphates
Before discussing radioactive labelling methods in inositol polyphosphate research,
we must briefly introduce these molecules and the metabolic pathways connecting
them. As it is not the main scope of this essay, discussion of inositol polyphosphate
metabolism will be highly simplified; the interested person is encouraged to read the
following more comprehensive reviews [15–18]. The carbon backbone of myo-
inositol (hereafter simply called ‘‘inositol’’) is by far the most common and
biologically relevant of the naturally occurring stereoisomers. It is also the structural
building block for the inositol polyphosphates. In its favoured chair conformation,
inositol has five equatorial and one axial hydroxyl group (Fig. 2a) [19]. This axial
hydroxyl is found at the carbon in position 2, using the D-numbering convention for
cyclitols.
The simplest function of inositol is as an osmolyte, whose cellular concentration
is regulated in response to hyperosmolarity. However, more interesting functions
are achieved through phosphorylation to create inositol polyphosphates. These
water-soluble molecules have a complicated biosynthetic pathway in yeast and,
presumably, in mammalian cells: not just sequential phosphorylation or dephos-
phorylation, but synthesis that is intimately linked to the metabolism of the related
PtdIns lipids (Figs. 1, 3) [20, 21]. Cells can synthesise inositol de novo from
glucose-6-phosphate or acquire it from the extracellular environment, allowing it to
enter the inositol cycle (Fig. 1). Inositol lipid synthesis starts with the activation of
PA with CTP, becoming CDP-DAG that is subsequently attached to the 1-hydroxyl
of the inositol ring, forming PtdIns. This can be phosphorylated to PtdIns(4)P and
then to PtdIns(4,5)P2, the substrate for phospholipase C (PLC), in the calcium
release signalling paradigm described above. It is important to remember that the
universal production of Ins(1,4,5)P3 by PLC does not necessarily translate into
calcium signalling, as many eukaryote clades including yeast and plants do not
possess InsP3 receptors [22]. The Ins(1,4,5)P3 generated by PLC activity can be
dephosphorylated back to inositol and reused for PtdIns synthesis. Conversely,
Ins(1,4,5)P3 can act as precursor for a large, diverse family of higher phosphorylated
inositol polyphosphates (Fig. 3). For example, Ins(1,4,5)P3 is a substrate of the
inositol polyphosphate multikinase (IPMK; yeast Arg82) [23–26], which is able to
phosphorylate both positions 3 and 6, creating Ins(1,3,4,5,6)P5. This is acted on by
inositol pentakisphosphate 2-kinase (IP5-2K or IPPK; Ipk1 in yeast) [27, 28] to
create the fully phosphorylated inositol hexakisphosphate (InsP6 or phytic acid).
Another metabolic route can also lead to Ins(1,3,4,5,6)P5 synthesis. Phosphorylation
of Ins(1,4,5)P3 by ITPKA,B,C, the IP3-3Ks, generates Ins(1,3,4,5)P4 [29, 30] that is
dephosphorylated by 5-phosphatases such as SHIP1 into a different InsP3 isomer,
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Fig. 2 myo-Inositol structure and its radiolabelled derivatives. While nine stereoisomeric configurations
of inositol are possible, the structure of myo-inositol is depicted in (a), referred to in the review simply as
inositol, since it is by far the most common and biologically relevant form of inositol. The modern
D-numbering system for inositols is counterclockwise as viewed from above and assigns the single axial
hydroxyl group of myo-inositol to the carbon in position 2, while the other five hydroxyls are equatorial.
myo-Inositol possesses an axis of symmetry through carbons 2 and 5 (dashed line), making positions 1,3
and 4,6 enantiomeric. The most common commercially available tritium-labelled inositol (b) possess the
[3H] radiolabelled in position 1 and/or 2, while in [14C]inositol the radiolabel is uniformly distributed (c)
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Ins(1,3,4)P3. This isomer is a substrate for ITPK1, another multikinase, which adds
a phosphate group at positions 5 and 6, again resulting in an InsP5 species with the
remaining hydroxyl group at the 2 position [31–33] (Fig. 3). Furthermore ITPK1
can also phosphorylate position 1 of the inositol ring [34, 35].
Together, Ins(1,3,4,5,6)P5 and InsP6 are the major forms of inositol polyphos-
phates present in mammalian cells. Despite their association with numerous cellular
functions, and unlike Ins(1,4,5)P3, no dramatic or rapid changes in the cellular
amount of either molecule are seen on receptor activation, although their relative
level is modulated by neurotrophin signals [36]. However, they are not metabol-
ically inert: Ins(1,3,4,5,6)P5 and InsP6 are substrates for the synthesis of a subfamily
of inositol polyphosphates called inositol pyrophosphates [37–39]. These contain
one or more high-energy phosphoanhydride (pyro) bonds as well as the phospho-
esters. Two classes of enzyme synthesise inositol pyrophosphates in mammalian
cells. The IP6Ks (InsP6 kinase) are able to pyrophosphorylate position 5 of the
inositol ring, generating 5PP-InsP5 (diphosphoinositol pentakisphosphate, InsP7)
from InsP6 or 5PP-InsP4 from Ins(1,3,4,5,6)P5 [25, 38–43]. Alternatively, PPIP5K
(VIP1 in yeast) enzymes can pyrophosphorylate position 1, generating the 1PP-
InsP5 isomer of InsP7 from InsP6 in vitro [44–47], and InsP8 ([PP]2-InsP4; bis-
diphosphoinositol-tetrakisphosphate) from 5PP-InsP5 in vivo [48, 49].
The characterised inositol phosphate kinases (Table 1) offer the opportunity to
label the inositol ring with radioactive phosphate simply by performing in vitro
enzymatic reactions using recombinant enzyme with radioactive [32P]cATP. We
will first introduce the radioactive isotopes available, before describing their use.
3 Radioactive Labels for Inositol
Inositol polyphosphates consist of four different atomic species: for example, the
chemical formula of the fully phosphorylated inositol ring of InsP6 is C6H18O24P6.
Of these elements, oxygen does not have relevant long-lived radioisotopes and
therefore is not used for radiolabelling. Conversely, it is possible to generate useful
unstable, and thus radioactive, isotopic species for carbon, hydrogen and phospho-
rus. We will briefly describe the biophysical characteristics of the most commonly
bFig. 3 Inositol polyphosphates synthetic pathway. The synthesis of higher phosphorylated inositol
polyphosphates begins with the synthesis of Ins(1,4,5)P3. Saccharomyces cerevisiae uses only
phospholipase C (PLC) hydrolysis of the lipid PI(4,5)P2 to synthesise Ins(1,4,5)P3 [28], whereas
Dictyostelium discoideum utilises the cytosolic route, of which the enzymology is not fully elucidated
(dashed line) [110]. Ins(1,4,5)P3 is metabolised by ITPKA, B, or C to synthesise Ins(1,3,4,5)P3, which is
acted on by the 5-phosphatase (grey line) to generate the Ins(1,3,4)P3 converted by ITPK1 to
Ins(1,3,4,5,6)P5. However, this isomer of InsP5 can also be directly generated by IPMK from Ins(1,4,5)P3.
InsP5 is converted to InsP6 by the IP5-2Kinase IPPK. Phosphorylation of InsP6 by the IP6Ks generates the
inositol pyrophosphate InsP7, specifically the depicted isomer 5PP-InsP5, which is further acted on by
PPIP5K1,2 to IP8, specifically to 1,5(PP)2-IP4. The IP6K enzymes can also use Ins(1,3,4,5,6)P5 as a
substrate, generating the inositol pyrophosphate PP-IP4. In this figure, for visual reasons, inositol is
abbreviated as ‘‘I’’ instead of ‘‘Ins’’, and phosphatidylinositol as ‘‘PI’’ instead ‘‘PtdIns’’. Kinases
catalysing each step are indicated in red (human) and blue (S. cerevisiae)
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used radioisotopes: tritium [3H], carbon [14C], and phosphorus [32P] and [33P]
(Table 2). All are radioactive due to b decay.
Tritium contains two neutrons as well as the usual hydrogen proton. It is a weak
b-emitter with a half-life of over 12 years. The emitted electron has very low
energy, and can therefore travel only a few millimetres in air, and cannot penetrate
the skin. This makes it particularly easy to work with, as special protective
equipment is not required: gloves, goggles and lab coat are sufficient. On the minus
side, the emitted radiation is too low to be detected by Geiger counter. Testing for
tritium contamination before and after an experiment must instead be performed by
swipe testing and liquid scintillation counting. Carbon-14 has a very long half-life,
enabling its use in carbon dating in archaeology. The emitted electrons are still
reasonably low-energy, although they can be detected using a Geiger counter, and
Table 1 Inositol phosphate kinases identified in the human and yeast (S. cerevisiae) genomes
Inositol
polyphosphate
kinase
Human Yeast Main enzymatic activities References
Inositol-
trisphosphate
3-kinase
ITPKA,B,C – Ins(1,4,5)P3 =[ Ins(1,3,4,5)P4 [74, 105–107]
Inositol
polyphosphate
multikinase
IPMK Arg82 Ins(1,4,5)P3 =[ Ins(1,3,4,5)P4
Ins(1,3,4,5)P4 =[ Ins(1,3,4,5,6)P5
PtdIns(4,5)P2 =[PtdIns(3,4,5)P2
[23–26]
Inositol-
tetrakisphosphate
1-kinase
ITPK1 – Ins(1,3,4)P3 =[ Ins(1,3,4,5)P4
Ins(1,3,4,5)P4 =[ Ins(1,3,4,5,6)P5
Ins(3,4,5,6)P4 =[ Ins(1,3,4,5,6)P5
[32, 33, 35, 85, 108]
Inositol
pentakisphosphate
2-kinase
IPPK Ipk1 Ins(1,3,4,5,6)P5 =[ InsP6 [27, 28]
Inositol
hexakisphosphate
kinase
IP6K1,2,3 Kcs1 InsP6 =[ 5PP-InsP5
1PP-InsP5 =[ (1,5)PP2-InsP4
Ins(1,3,4,5,6)P5 =[ PP-InsP3
[25, 42, 83]
Diphosphoinositol
pentakisphosphate
kinase
PPIP5K1,2 Vip1 InsP6 =[ 1PP-InsP5
5PP-InsP5 =[ (1,5)PP2-InsP4
[44–47, 109]
Table 2 Isotopic labels available to generate inositol polyphosphate radioactive tracers
Symbol b energy Range in air Half-life
Tritium, hydrogen-3 [3H] 5.7 keV \1 cm 12.3 years
Carbon-14 [14C] 156 keV 24 cm 5730 years
Phosphorus-32 [32P] 1709 keV 610 cm 13.5 days
Phosphorus-33 [33P] 249 keV 89 cm 25.4 days
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can travel less than 0.3 mm into the skin. Therefore, shielding is also not necessary
when working with [14C].
Phosphorus-32 is the most energetic radioisotope commonly used in biochemical
laboratories. The electrons released are very high-energy and can travel over 6 m
through air and 0.76 cm into human tissues. Consequently, extra precautions are
required when working with [32P]: a 1 cm Plexiglas shield is required for the
working area, and dosimeter monitoring for the experimenter. Contamination is
easily detected with a Geiger counter. Experiments requiring [32P] can also be
performed using the superior phosphorus-33 isotope. The emitted radiation from
[33P] is of lower energy and is therefore less dangerous, although the same safety
measures are required. The half-life of [33P] is also longer than that of [32P]:
25.4 days compared to 14.3 days. This can be extremely beneficial in maximising
the value of any radiolabelled compounds synthesised. Only very rare experimental
circumstances require the high energy of [32P] radiation, but this isotope is still
widely used, since there is a huge price difference between the two radioactive
isotopes. Phosphorus-33 is much more expensive.
4 Inositol Polyphosphate in Vivo Studies Using Radioactive Metabolic
Labelling
As mentioned above, the main problem for inositol polyphosphate research is that
there is no easy way to detect the inositol ring using spectrophotometry. A technique
was developed in the 1980s that combined chromatography, post-column derivati-
sation and spectrophotometry to visualise the phosphate groups, and thus indirectly
the inositol polyphosphate, to try to solve this problem [50]. This method is not
sensitive enough to be routinely used with mammalian cells, although there are a
few reports of its use [46]; it may be more appropriate for organisms with high
levels of inositol polyphosphates such as the amoeba Dictyostelium discoideum
[3, 51]. In general, for effective, sensitive and reliable methods for detecting and
studying the metabolism and many functions of inositol polyphosphates, we must
turn to radioactivity.
The standard procedures for investigating inositol polyphosphate metabolism
in vivo require the use of radiolabelled inositol tracers [52, 53]. These are usually
based on tritium labels, with carbon-14 rarely used, as it is more expensive (Fig. 2b,
c). These [3H]inositol or [14C]inositol tracers (Fig. 2b, c) are added to the
extracellular growth medium, where they are taken up by cells and enter the inositol
cycle (Figs. 1, 3). Different inositol polyphosphates and phosphoinositides then
begin to be radiolabelled. The labelling must be given sufficient time to reach
isotopic equilibrium, where all the inositol polyphosphates species are in
equilibrium with [3H]inositol or [14C]inositol. Given the presence of more than
30 inositol polyphosphate species in eukaryote cells [15, 17], and that, for example,
seven sequential enzymatic reactions are required to generate InsP7, it is clear that
allowing time to reach isotopic equilibrium is fundamental to generating reliable
experimental data. For yeast, it is normally sufficient to label the cells overnight,
which corresponds to 7–8 cell divisions. Unsurprisingly, mammalian cells must be
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labelled for much longer to reach equilibrium: 4 or 5 days may be enough,
depending on cell type. Before starting labelling experiments in a new cell type, a
pilot study must be performed to determine the time needed to reach metabolic
equilibrium [36]. This is calculated by dividing the radioactivity accumulated in
InsP6 by the radioactivity of the lipid phosphoinositide pool. This InsP6/phospho-
inositide ratio increases over time; when it remains constant, the labelling has
reached equilibrium. In the modern literature, too often the isotopic equilibrium is
not properly calculated or even considered, casting doubt on the reliability of the
data generated.
Once metabolic equilibrium has been reached, radiolabelled inositol polyphos-
phates can be acid-extracted and resolved by strong anion exchange high-
performance liquid chromatography (saxHPLC). Two options exist for analysing
the samples. Firstly, an in-line radioactivity detector can be used, greatly speeding
up analysis and reducing handling at the cost of sensitivity. The alternative is to
collect fractions for manual counting with a scintillation b-counter; while more
labour-intensive, this method significantly increases the sensitivity. The inositol
pyrophosphate species InsP7 and InsP8 can be easily detected in labelled yeast
extracts using manual counting [52, 54], while only the more abundant precursor
InsP6 has been identified using in-line detectors [28].
It should also be mentioned that dual isotopic labelling is possible. The difference
in the energy of electrons emitted by [3H]inositol and [14C]inositol enables
scintillation counters to distinguish these two inositol species. By labelling cells to
isotopic equilibrium using [14C]inositol, and then briefly with [3H]inositol, it is
possible to study the possible heterogeneity within pools of phosphoinositides or
inositol polyphosphates [55]. This approach was employed successfully in the study
of inositol polyphosphates generated after vasopressin or prostaglandin stimulation
of vascular tissue. Their source was found to be rapidly labelled phosphoinositides,
while the bulk of the highly phosphorylated inositol polyphosphates InsP5 and InsP6
were not created from the rapid phosphoinositide turnover, and were therefore
deemed metabolically inert [56]. Dual labels can also have more technical uses.
Chiefly, a second isotopic label is widely used to determine chromatographic
saxHPLC peak identity: spiking a [3H]inositol labelled extract with a [14C]inositol
polyphosphate standard enables conclusive identification of the nature of the eluted
peaks [24].
The use of commercially available radiolabelled standards would of course be
ideal. Unfortunately, many inositol polyphosphates, including InsP7, are not
available commercially in their radiolabelled form or often even in unlabelled
format. The next best option for peak identification is to use the well-characterised
yeast inositol kinase mutant strains. Separation of radiolabelled wild-type yeast
extracts by saxHPLC reveals a simple elution profile with one major peak of InsP6
and two smaller, more polar and therefore later-eluting peaks of InsP7 and InsP8.
These two peaks are absent in extracts from kcs1D (IP6K mutant) yeast. The vip1D
mutant instead accumulates InsP7 [48, 49]. Other mutants show increased peaks for
inositol polyphosphates: Ins(1,4,5)P3 accumulates in arg82D multikinase mutants
[23], while Ins(1,3,4,5,6)P5 accumulates and is converted by Kcs1 into PP-IP4 in an
ipk1D mutant. The ipk1Dkcs1D double mutant has only the increased InsP5 peak
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[54]. Radiolabelled inositol polyphosphate standards can also be generated in vitro
enzymatically, whether using radioactive inositol polyphosphate precursors or cold
inositol polyphosphates with [32P]cATP (as described below). Laboratories with a
serious interest in inositol polyphosphate analysis would do well to create standards
with a long half-life: extracting and purifying specific inositol polyphosphates from
[3H]inositol- or [14C]inositol-labelled cells gives defined standards that can be used
over several years [24, 57].
While radioactive orthophosphate labelling has been instrumental in the early
development [58–60] of the inositol phosphate research field, it must be admitted
that [32P] or [33P] orthophosphate labelling currently has limited use for in vivo
analysis of inositol polyphosphate metabolism. Many phosphorylated molecules in
eukaryotic cells, primarily the abundant nucleotides, are co-purified during the
acidic extraction normally employed to purify inositol polyphosphates. Therefore,
any chromatogram is essentially undecipherable until the nucleotides have eluted
off. The interfering nucleotides can be removed first by charcoal treatment, but this
complicates the extraction procedure [61]. For this reason, only a handful of papers
published after the 1990s have reported the use of phosphate labelling to study
inositol polyphosphate metabolism in vivo. One such use was the original
identification of inositol pyrophosphates in D. discoideum extracts [3]: the
saxHPLC elution region for these high-polarity molecules in this organism is
conveniently free from interference from contaminating phosphorylated molecules.
This is not the case for extracts from cell types rich in the linear polymer of
phosphates [62, 63] inorganic polyphosphate (polyP), such as yeast or try-
panosomes, where polyP is particularly abundant [64–66]. In these organisms,
orthophosphate labelling experiments will reveal the continuous presence through-
out the chromatogram of radiolabelled polyP peaks that cover the InsP6, InsP7 and
InsP8 signals (A. Saiardi, unpublished observation).
Orthophosphate labelling using [32P] or [33P] is more useful in studies of PtdIns
lipids. While several types of potentially contaminating phospholipids exist, their
number is not as great as the water-soluble (i.e., acid-extracted) phosphorylated
molecules present in eukaryotic cytosol. Furthermore, nucleotides are eliminated by
the organic solvent extraction procedure required to purify phosphoinositides. Thus
it is possible to identify and study radiolabelled phosphoinositides directly, using
thin-layer chromatography (TLC) or by resolution by saxHPLC after deacylation
[67]. The highly energetic phosphate isotopes also allow the use of in-line
radioactive detection methods to measure the saxHPLC-eluted deacylated lipids. It
is important to note that orthophosphate [32P] or [33P] labelling is usually performed
over a short period of time, from a few minutes to a few hours only. The phosphorus
isotopes are toxic to the cell, and incubation over a few days induces cell stress or
even death. Furthermore, orthophosphate labelling does not require reaching any
isotopic equilibrium. Tritium or [14C] labels are components of the inositol ring
itself (Fig. 1b, c), while phosphate labels are not: they are added and removed by the
dynamic action of specific phosphatases and kinases, and thus isotopic equilibrium
labelling is not necessary.
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5 Biochemical Synthesis of 32/33Phosphate Radiolabelled Inositol
Polyphosphates
Even before the cloning of inositol polyphosphate kinases, allowing the synthesis and
purification of recombinant enzymes from bacteria, partially purified enzymatic
activities or simple cell extracts were used to synthesise radiolabelled inositol
polyphosphates [68, 69]. The synthesis of these molecules, labelled with radioactive
phosphate at specific positions of the ring, has had numerous applications, including as
standards, for monitoring enzymatic activity, or even the discovery of the new post-
translational modification protein pyrophosphorylation. Most of the metabolic
pathways and functions of lower phosphorylated inositol polyphosphates were
elucidated before the cloning of the kinases responsible for their synthesis, often using
elegant [32P] radiolabelled biochemical assays [70–73]. Studies of the functions of the
higher phosphorylated inositol polyphosphates, such as InsP5, InsP6, and their inositol
pyrophosphate derivatives have benefitted from this previous knowledge and by the
cloning of their kinases. Using one of the six now known inositol polyphosphate
kinases (Table 1) and [32/33P]cATP, it is possible to label almost any position of the
inositol ring with radioactive phosphate. We will start by discussing the use of
recombinant ITPKA, an IP3-3 kinase, to generate InsP4 labelled at position 3.
6 Synthesis of [32P]i Radiolabelled InsP4 and Its Use
The biosynthesis of [32P]InsP4 can be achieved by incubating ITPKAwith Ins(1,4,5)P3
and [32P]cATP. This enzyme specifically phosphorylates position 3 of the ring, and
thus generates 3[32P]Ins(1,3,4,5)P4 [74]. Several studies have used this method to
investigate the metabolism of this isomer. Notably, its degradation by inositol
polyphosphate 5-phosphatases (namely SHIP1/2) can be studied by following the
formation of the radiolabelled and thus easily traceable 3[32P]Ins(1,3,4)P5 [75]. The
anabolism of 3[32P]Ins(1,3,4,5)P4 and conversion to [
32P]InsP6 has also been studied
after incubation with nuclear extracts from D. discoideum [76].
SHIP2 is more famous for its ability to convert PtdIns(3,4,5)P3 to PtdIns(3,4)P2,
thus regulating the signal from these two important lipids [77]. To study SHIP activity
against lipids, radiolabelled [32P]PtdInsP3 substrate may be required. Previously,
PI3Kswere employed to create this, but these are large proteins forwhich recombinant
expression from bacteria is difficult. A current alternative is to use IPMK, which can
act on not only the soluble InsP(1,4,5)P3 but also the lipid PtdIns(4,5)P2 [78], allowing
straightforward synthesis of 3[32P]PtdIns(3,4,5)P3, specifically labelled in position 3
[79]. Human IPMK is easily produced from Escherichia coli [26, 78].
7 Preparing [32P]i Radiolabelled InsP5 and Its Use
Several inositol phosphate kinases are quite promiscuous. IPMK, as the name states,
is a multikinase able to phosphorylate the inositol ring at positions 4 and 6, but also
shows, at least in vitro, the ability to convert InsP5 to the inositol pyrophosphate PP-
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InsP4 [26, 80]. As noted above, it is also able to phosphorylate the lipid
PtdIns(4,5)P2 to PtdIns(3,4,5)P3 [78, 81]. The IP6Ks can metabolise several isomers
of InsP5 and InsP6 to inositol pyrophosphates [82, 83]. But perhaps the inositol
phosphate kinase most catalytically flexible is ITPK1, which while primarily
characterised as a 5- and 6-kinase (Fig. 3) [33], in certain species also has the ability
to phosphorylate position 1 of the inositol ring [35]. This activity enables the
synthesis of 1[32P]Ins(1,3,4,5,6)P5 [84] by incubating Ins(3,4,5,6)P4 with [
32P]cATP
in the presence of Entamoeba histolytica ITPK1 produced in E. coli [85] (Fig. 4).
Using 1[32P]Ins(1,3,4,5,6)P5, an intriguing intersubstrate phosphate transfer activity
was also discovered for ITPK1. In the presence of 1[32P]Ins(1,3,4,5,6)P5 and ADP,
human ITPK1 transfers the radioactive phosphate, generating [32P]cATP and
Ins(3,4,5,6)P4. The addition of Ins(1,3,4)P3 to this reaction augmented the rate of
dephosphorylation of 1[32P]Ins(1,3,4,5,6)P5, as Ins(1,3,4)P3 now became the
acceptor of the radioactive phosphate group, forming radiolabelled
[32P]Ins(1,3,4,5/6)P4 phosphorylated at the 5 or 6 position, plus again Ins(3,4,5,6)P4
[84]. Thus the use of radioactive 1[32P]Ins(1,3,4,5,6)P5 enabled elucidation of how
human ITPK1 regulates the synthesis of Ins(3,4,5,6)P4, a signalling molecule
fundamental to controlling chloride channel conductance [31, 32]. It was later
demonstrated, again using 1[32P]Ins(1,3,4,5,6)P5, that ITPK1 from the plant
Solanum tuberosum possesses similar intersubstrate phosphotransferase activity
[86].
Fig. 4 Schematic synthesis of radiolabelled InsP5. The most abundant inositol pentakisphosphate
isomer, Ins(1,3,4,5,6)P5, is the common end product of two multikinases, IPMK and ITPK1, using
different starting inositol triphosphates (see Fig. 3). Therefore, using these two enzymes and different
species of InsP3 and InsP4, it is possible to generate InsP5 labelled in different positions of the inositol
ring. The top reaction illustrates the ability of Entamoeba histolytica ITPK1 (EhITPK1) to phosphorylate
position 1 [34, 35], enabling specific synthesis of 1[32P]Ins(1,3,4,5,6)P5. Conversely, the bottom reaction
uses the mammalian IPMK, a 3,6 kinase. Recombinant IPMK can thus be used to generate radiolabelled
3,6[32P]Ins(1,3,4,5,6)P5 [88]. Different atoms are colour-coded as follows: carbon black circle; oxygen
green circle; phosphate yellow circle; radioactive phosphate red circle
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A different [32P]Ins(1,3,4,5,6)P5 radiolabelled isomer was initially purified from
metabolically labelled cells [72, 87]. It can now be made using IPMK with
Ins(1,4,5)P3 and [
32P]cATP, generating 3,6[32P]Ins(1,3,4,5,6)P5 (Fig. 4). Similarly,
[3H]Ins(1,3,4,5,6)P3 is generated by incubating recombinant IPMK with the
commercially available [3H]Ins(1,3,4,5)P4 and ATP. Both radiolabelled reagents
3,6[32P]Ins(1,3,4,5,6)P5 and [
3H]Ins(1,3,4,5,6)P5 have been employed to great effect
in studying the metabolic stability of InsP5 and its anti-tumour capability [88].
8 Preparing [32P]i Radiolabelled InsP6 and Its Use
The commercial availability of [3H]InsP6 has been intermittent over the years. This
is unfortunate, as it was indispensable, for example, in the cloning of the IP6K
enzymes from rat brain homogenate: the conversion of [3H]IP6 to [
3H]InsP7 was
followed using polyethylenimine cellulose thin-layer chromatography (PEI-TLC)
[25, 68]. The custom synthesis of [32P]InsP6 was similarly essential to the
identification of the other class of enzymes, PPIP5Ks, able to synthesise inositol
pyrophosphates. High specific activity [32P]InsP6 can be generated enzymatically by
incubating Ins(1,3,4,5,6)P5 and [
32P]cATP with recombinant Arabidopsis thaliana
IPK1 enzyme [89]. After HPLC purification, this enzymatic reaction generates
[32P]IP6 specifically labelled in position 2, i.e., 2[
32P]Ins(1,2,3,4,5,6)P6. The use of
this compound spurred the identification, cloning and characterisation of the yeast
PPIP5K (Vip1), since its conversion to [32P]InsP7 by kcs1D (IP6K deletion) yeast
extracts revealed the presence of another inositol pyrophosphate synthase activity
[47]. Radiolabelled [32P]InsP6 has also been used to follow IP6K activity during the
yeast cell cycle [90] by simply resolving radioactive [32P]IP6 and [
32P]IP7 by PEI-
TLC. In addition to eliminating the need for a sophisticated HPLC apparatus, this
experimental approach is quantitative, since the radioactivity present in the
[32P]InsP6 and [
32P]InsP7 TLC spots can be measured by scraping and counting
them in a scintillation counter.
9 Preparing [32P]i Radiolabelled InsP7 and Its Use in Protein
Pyrophosphorylation Reactions
The inositol pyrophosphates InsP7 and InsP8 have been linked to many cellular
roles, but the mechanism is not clear. These are known to be dynamic molecules,
unlike their ‘‘metabolically inert’’ precursor InsP6 [2]: in mammalian cells, up to
50% of the pool of InsP6 may be converted to InsP7 or InsP8 per hour [91]. One
possible mode of action for InsP7 is protein pyrophosphorylation, in which the b-
phosphate is donated to a pre-phosphorylated serine, becoming InsP6 and generating
a pyrophosphoserine residue. The discovery of this post-translational modification
followed the cloning of IP6K1 [25] and the subsequent ability to synthesise InsP7
radiolabelled at the b-position of the pyrophosphate moiety, 5[32P]bInsP7 (Fig. 5),
using InsP6 and [
32P]cATP [92]. Synthesis must be followed by a saxHPLC
purification procedure to remove any leftover [32P]cATP. Radiolabelled
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5[32P]bInsP7 fractions are then ready to use following desalting with a Sep-Pak
QMA cartridge and concentration with a centrifugal evaporator [52]. Experiments
demonstrated kinase-independent phosphorylation of multiple proteins in vitro [93].
In the absence of alternative detection methods, the use of the labelled 5[32P]b InsP7
is still reported in all publications of serine pyrophosphorylation [94–96].
Performing the in vitro pyrophosphorylation/transphosphorylation experiment,
once 5[32P]bInsP7 is synthesised, is a straightforward process. However, it is
important to remember the requirement for a pre-phosphorylated serine residue as
substrate. Thus proteins of bacterial origin, such as recombinant mammalian
proteins expressed in E. coli, require a priming event by a classical ATP kinase,
usually casein kinase 2 (CK2) [93, 94]. The 5[32P]bInsP7 pyrophosphorylation is a
non-enzymatic, temperature-dependent event that, while it does occur at physio-
logical temperatures, is enhanced by incubating the sample at higher temperatures
[97]. Once pyrophosphorylated, proteins can be resolved by polyacrylamide gel
electrophoresis (PAGE), and their radioactivity incorporation can be easily
identified by autoradiography. Several substrates of InsP7-mediated pyrophospho-
rylation have been identified so far. A common feature to all is stretches of serines
embedded in regions rich in acidic residues; as magnesium is required for
pyrophosphorylation, it is possible that the acidic residues are required to coordinate
these ions. Pyrophosphorylated proteins are more acid-labile but also more resistant
to phosphatases than proteins phosphorylated by ATP alone [93]. If this is true
in vivo, it could have huge implications for cellular signalling: InsP7-mediated
protein pyrophosphorylation could act in a dominant manner to allow continued
signalling even during phosphatase activation.
Fig. 5 Schematic synthesis of radiolabelled 5[32P]bInsP7. Two different InsP7 isomers can be easily and
rapidly synthesised biochemically, using recombinant IP6K1 or the kinase domain of PPIP5K1 (or its
yeast counterpart Vip1). Using radiolabelled [32P]cATP and InsP6 as substrate, IP6K1 generates
5[32P]bInsP7 (top), thus transferring the radioactive [
32P] from ATP to the phosphorylated position 5 of
InsP6. PPIP5K instead generates the isomer 1[
32P]bInsP7 (bottom). Different atoms are colour-coded as
follows: carbon black circle; oxygen green circle; phosphate yellow circle; radioactive phosphate red
circle
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It is important to note that inositol pyrophosphates appear to be interchangeable
in their ability to pyrophosphorylate proteins. For example, 1[32P]bInsP7 synthe-
sised using the Vip1 (PPIP5K) kinase domain and [32P]cATP (Fig. 5) is able to
pyrophosphorylate proteins, as is 1,5[32P]InsP8 synthesised by the double action of
IP6K1 and Vip1. In fact, the incubation of S. cerevisiae extracts with 5[32P]bInsP7,
1[32P]bInsP7 or 1,5[
32P]bInsP8 revealed an identical pattern of pyrophosphorylated
proteins [93]. This indicates that if pyrophosphorylation is the mechanism of action
for inositol pyrophosphates, they can substitute for each other in performing their
biological role. However, allosteric regulation of proteins has also been proposed as
a mechanism [98, 99], and in this circumstance, different isomeric species of
inositol pyrophosphates could be recognised by specific effector proteins.
The synthesis described here for 5[32P]bInsP7 is a straightforward procedure, as
is using it to identify pyrophosphorylated proteins. However, processing millicurie
amounts of radioactivity to generate a reagent with a two week half-life requires a
degree of dedication. Therefore, protein pyrophosphorylation, while considered an
exciting post-translational modification, has received little attention, as only a
handful of laboratories have invested in the synthesis of 5[32P]bInsP7. The recent
development of organic synthesised experimental tools to study protein pyrophos-
phorylation [100, 101] will likely lead to the further and very welcome development
of non-radioactive detection methods, and to the demonstration of the existence of
this modification in vivo. These developments will certainly increase interest in
protein pyrophosphorylation, but it must be remembered that it was the innovative
use of radioactive labelling methods that permitted the discovery of this
modification in the first place. This is an excellent demonstration that original
radioactive assays should not be avoided.
10 Perspective
In today’s ‘‘omics’’ era, radioactive labelling appears anachronistic. Current
proteomic, metabolomic or genomic studies give us plentiful information in an ever-
growing number of databases. Ultimately, however, these huge amounts of data
must not be just statistically annotated, but must drive biochemistry experiments,
which as noted before, provide the only experimental basis for the understanding of
biological mechanisms [102, 103]. In this context, radioactive molecular tracers
have played and will continue to play a contributory role in our quest to understand
the molecular mechanisms of life.
This review has highlighted the fundamental importance of radioactive labelling
in the birth and the development of inositol polyphosphate research. Although
recent technological development efforts such as PAGE analysis [82] and TiO2
extraction of inositol polyphosphates [104] are facilitating the study of the
metabolism and functions of these molecules without the need for radioactive
precursors or metabolic labelling, we definitely foresee further need for phosphate-
32/33-, carbon-14- or tritium-based experiments to fully appreciate the importance
of these molecules in cell biology.
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